Search Results - "Lara Hosey"

High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group by Shiboski, Caroline H, Chen, Huichao, Secours, Rode, Lee, Anthony, Webster-Cyriaque, Jennifer, Ghannoum, Mahmoud, Evans, Scott, Bernard, Daphné, Reznik, David, Dittmer, Dirk P, Hosey, Lara, Sévère, Patrice, Aberg, Judith A

“…Many studies include oral HIV-related endpoints that may be diagnosed by non-oral-health specialists (non-OHS) like nurses or physicians. Our objective was to…”
Get full text

Temporal Dissociation of Early Lexical Access and Articulation Using a Delayed Naming Task — An fMRI Study by Kemeny, Stefan, Xu, Jiang, Park, Grace H., Hosey, Lara A., Wettig, Carla M., Braun, Allen R.

“…Neuroimaging studies of overt speech hold an important practical advantage allowing monitoring of subject performance, particularly valuable in disorders like…”
Get full text

Neural bases of categorization of simple speech and nonspeech sounds by Husain, Fatima T., Fromm, Stephen J., Pursley, Randall H., Hosey, Lara A., Braun, Allen R., Horwitz, Barry

“…Categorization is fundamental to our perception and understanding of the environment. However, little is known about the neural bases underlying the…”
Get full text

Effect of Concomitantly Administered Rifampin on the Pharmacokinetics and Safety of Atazanavir Administered Twice Daily by ACOSTA, Edward P, KENDALL, Michelle A, HAAS, David W, GERBER, John G, ALSTON-SMITH, Beverly, KOLETAR, Susan L, ZOLOPA, Andrew R, AGARWALA, Sangeeta, CHILD, Michael, BERTZ, Richard, HOSEY, Lara

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Feeling of knowing for names in response to faces by Hosey, Lara A., Peynircioğlu, Zehra F., Rabinovitz, Brian E.

“…Participants were asked to recall the names when shown photographs of faces in both a semantic task (Experiment 1) and an episodic task (Experiments 2 and 3)…”
Get full text

Selective left, right and bilateral stimulation of subthalamic nuclei in Parkinson's disease: differential effects on motor, speech and language function by Schulz, Geralyn M, Hosey, Lara A, Bradberry, Trent J, Stager, Sheila V, Lee, Li-Ching, Pawha, Rajesh, Lyons, Kelly E, Metman, Leo Verhagen, Braun, Allen R

“…Deep brain stimulation (DBS) of the subthalamic nucleus improves the motor symptoms of Parkinson's disease, but may produce a worsening of speech and language…”
Get more information

Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trial by Gross, Robert, Dr, Zheng, Lu, PhD, Rosa, Alberto La, MD, Sun, Xin, MS, Rosenkranz, Susan L, PhD, Cardoso, Sandra Wagner, MD, Ssali, Francis, MBBCh, Camp, Rob, Godfrey, Catherine, MD, Cohn, Susan E, Prof, Robbins, Gregory K, MD, Chisada, Anthony, MD, Wallis, Carole L, PhD, Reynolds, Nancy R, Prof, Lu, Darlene, MS, Safren, Steven A, Prof, Hosey, Lara, MA, Severe, Patrice, MD, Collier, Ann C, Prof

“…Summary Background Adherence is key to the success of antiretroviral therapy. Enhanced partner support might benefit patients with previous treatment failure…”
Get full text

ACTIV-2: A Platform Trial for the Evaluation of Novel Therapeutics for the Treatment of Early COVID-19 in Outpatients by Currier, Judith S, Moser, Carlee, Eron, Joseph J, Chew, Kara W, Smith, Davey M, Javan, Arzhang Cyrus, Wohl, David Alain, Daar, Eric S, Hughes, Michael D

“…Abstract Clinical Trials Registration ClinicalTrials.gov Identifier: NCT04518410…”
Get full text

Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial by Krown, Susan E, Moser, Carlee B, MacPhail, Patrick, Matining, Roy M, Godfrey, Catherine, Caruso, Stephanie R, Hosseinipour, Mina C, Samaneka, Wadzanai, Nyirenda, Mulinda, Busakhala, Naftali W, Okuku, Fred M, Kosgei, Josphat, Hoagland, Brenda, Mwelase, Noluthando, Oliver, Vincent O, Burger, Henriette, Mngqibisa, Rosie, Nokta, Mostafa, Campbell, Thomas B, Borok, Margaret Z, Moses, Agnes, Kanyama, Cecilia, Mukwekwerere, Pamela, Gudza, Ivy, Chauwa, Felluna, Ulaya, Godwin, Kutto, Irene, Cheruiyot, Priscilla, Okello, Clement, Nakaganda, Annet, Koskei, Geoffrey, Keter, Winnie, Netto, Juliana, Baião, Tamiris, Govender, Iveshni, O'Connell-Maritz, Jessica, Cain, Kevin, Okanda, John, Cornelissen, Lynne, Van Schalkwyk, Marije, Sikhosana, Rejoice, Ngcobo, Minenhle, Lee, Jeannette Y., Harrison, Taylor, Wachsman, William, Shin, Katherine, Evans, Scott, Rothenberg, Jennifer, Hosey, Lara, McCarthy, Sean, Martinez-Maza, Otoniel, Rinaldo, Charles, Dittmer, Dirk, Fletcher, Courtney, Rudek, Michelle, Asmelash, Aida, Hughes, Valery, Schouten, Jeffrey, Shugarts, David, Kujinga, Tapiwanashe, Zadzilka, Amanda, Kerui, Fredrick, Robertson, Debora, Rooney, James, Sewal, Krishna, Gottshall, Brian

“…Optimal treatment regimens for AIDS-associated Kaposi sarcoma, a frequent contributor to morbidity and mortality among people with HIV, have not been…”
Get full text

Safety and Efficacy of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies Amubarvimab Plus Romlusevimab in Nonhospitalized Patients With COVID-19 by Evering, Teresa H, Chew, Kara W, Giganti, Mark J, Moser, Carlee, Pinilla, Mauricio, Wohl, David Alain, Currier, Judith S, Eron, Joseph J, Javan, Arzhang Cyrus, Bender Ignacio, Rachel, Margolis, David, Zhu, Qing, Ma, Ji, Zhong, Lijie, Yan, Li, D'Andrea Nores, Ulises, Hoover, Keila, Mocherla, Bharat, Choudhary, Manish C, Deo, Rinki, Ritz, Justin, Fischer, William A, Fletcher, Courtney V, Li, Jonathan Z, Hughes, Michael D, Smith, Davey, Daar, Eric S

“…Development of safe and effective SARS-CoV-2 therapeutics is a high priority. Amubarvimab and romlusevimab are noncompeting anti-SARS-CoV-2 monoclonal…”
Get full text

Impact of Tamoxifen on Vorinostat-Induced Human Immunodeficiency Virus Expression in Women on Antiretroviral Therapy: AIDS Clinical Trials Group A5366, The MOXIE Trial by Scully, Eileen P, Aga, Evgenia, Tsibris, Athe, Archin, Nancie, Starr, Kate, Ma, Qing, Morse, Gene D, Squires, Kathleen E, Howell, Bonnie J, Wu, Guoxin, Hosey, Lara, Sieg, Scott F, Ehui, Lynsay, Giguel, Francoise, Coxen, Kendyll, Dobrowolski, Curtis, Gandhi, Monica, Deeks, Steve, Chomont, Nicolas, Connick, Elizabeth, Godfrey, Catherine, Karn, Jonathan, Kuritzkes, Daniel R, Bosch, Ronald J, Gandhi, Rajesh T

“…Biological sex and the estrogen receptor alpha (ESR1) modulate human immunodeficiency virus (HIV) activity. Few women have enrolled in clinical trials of…”
Get full text

Symptom and Viral Rebound in Untreated SARS-CoV-2 Infection by Deo, Rinki, Choudhary, Manish C, Moser, Carlee, Ritz, Justin, Daar, Eric S, Wohl, David A, Greninger, Alexander L, Eron, Joseph J, Currier, Judith S, Hughes, Michael D, Smith, Davey M, Chew, Kara W, Li, Jonathan Z

“…Although symptom and viral rebound have been reported after nirmatrelvir-ritonavir treatment, the trajectories of symptoms and viral load during the natural…”
Get full text

Pooling Different Placebos as a Control Group in a Randomized Platform Trial: Benefits and Challenges From Experience in the ACTIV-2 COVID-19 Trial by Moser, Carlee B, Chew, Kara W, Ritz, Justin, Newell, Matthew, Javan, Arzhang Cyrus, Eron, Joseph J, Daar, Eric S, Wohl, David A, Currier, Judith S, Smith, Davey M, Hughes, Michael D

“…Abstract Adaptive platform trials were implemented during the coronavirus disease 2019 (COVID-19) pandemic to rapidly evaluate therapeutics, including the…”
Get full text

SARS-CoV-2 monoclonal antibody treatment followed by vaccination shifts human memory B cell epitope recognition suggesting antibody feedback by Bloom, Nathaniel, Ramirez, Sydney I, Cohn, Hallie, Parikh, Urvi M, Heaps, Amy, Sieg, Scott F, Greninger, Alex, Ritz, Justin, Moser, Carlee, Eron, Joseph J, Bajic, Goran, Currier, Judith S, Klekotka, Paul, Wohl, David A, Daar, Eric S, Li, Jonathan, Hughes, Michael D, Chew, Kara W, Smith, Davey M, Crotty, Shane, Coelho, Camila H

“…Therapeutic monoclonal antibodies (mAbs) have been studied in humans, but the impact on immune memory of mAb treatment during an ongoing infection has remained…”
Get full text

Viral and symptom rebound following anti-SARS-CoV-2 monoclonal antibody therapy in a randomized placebo-controlled trial by Chew, Kara W, McGinley, Brooke, Moser, Carlee, Li, Jonathan Z, Evering, Teresa H, Ritz, Justin, Javan, Arzhang Cyrus, Margolis, David, Wohl, David A, Hughes, Michael D, Daar, Eric S, Currier, Judith S, Eron, Joseph J, Smith, Davey M

“…We explored viral and symptom rebound after COVID-19 amubarvimab/romlusevimab monoclonal antibody therapy vs placebo in the randomized ACTIV-2/A5401 trial…”
Get full text

Immune Status and SARS-CoV-2 Viral Dynamics by Li, Yijia, Moser, Carlee, Aga, Evgenia, Currier, Judith S, Wohl, David A, Daar, Eric S, Ritz, Justin, Greninger, Alexander L, Sieg, Scott, Parikh, Urvi M, Coombs, Robert W, Hughes, Michael D, Eron, Joseph J, Smith, Davey M, Chew, Kara W, Li, Jonathan Z

“…Abstract Immunocompromised individuals are disproportionately affected by severe coronavirus disease 2019, but immune compromise is heterogenous, and viral…”
Get full text

Participant Perspectives in an HIV Cure-Related Trial Conducted Exclusively in Women in the United States: Results from AIDS Clinical Trials Group 5366 by Dubé, Karine, Hosey, Lara, Starr, Kate, Barr, Liz, Evans, David, Hoffman, Erin, Campbell, Danielle M, Simoni, Jane, Sugarman, Jeremy, Sauceda, John, Brown, Brandon, Diepstra, Karen L, Godfrey, Catherine, Kuritzkes, Daniel R, Wohl, David A, Gandhi, Rajesh, Scully, Eileen

“…Women remain underrepresented in HIV research. The AIDS Clinical Trials Group (ACTG) 5366 study was the first HIV cure-related trial conducted exclusively in…”
Get more information

Statistical Challenges When Analyzing SARS-CoV-2 RNA Measurements Below the Assay Limit of Quantification in COVID-19 Clinical Trials by Moser, Carlee B, Chew, Kara W, Giganti, Mark J, Li, Jonathan Z, Aga, Evgenia, Ritz, Justin, Greninger, Alexander L, Javan, Arzhang Cyrus, Bender Ignacio, Rachel, Daar, Eric S, Wohl, David A, Currier, Judith S, Eron, Joseph J, Smith, Davey M, Hughes, Michael D

“…Abstract Most clinical trials evaluating coronavirus disease 2019 (COVID-19) therapeutics include assessments of antiviral activity. In recently completed…”
Get full text

Variant-Specific Viral Kinetics in Acute COVID-19 by Ribeiro, Ruy M, Choudhary, Manish C, Deo, Rinki, Giganti, Mark J, Moser, Carlee, Ritz, Justin, Greninger, Alexander L, Regan, James, Flynn, James P, Wohl, David A, Currier, Judith S, Eron, Joseph J, Hughes, Michael D, Smith, Davey M, Chew, Kara W, Daar, Eric S, Perelson, Alan S, Li, Jonathan Z

“…Abstract Understanding variant-specific differences in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral kinetics may explain differences in…”
Get full text

Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial by Chew, Kara W, Taiwo, Babafemi O, Moser, Carlee, Daar, Eric S, Wohl, David Alain, Ritz, Justin, Javan, Arzhang Cyrus, Li, Jonathan Z, Fischer, William, Greninger, Alexander L, Bausch, Christoph, Luke, Thomas, Call, Robert, Neytman, Gene, Giganti, Mark J, Fletcher, Courtney V, Hughes, Michael D, Eron, Joseph J, Currier, Judith S, Smith, Davey M, Chew, Kara, Smith, David (Davey), Daar, Eric, Wohl, David, Currier, Judith, Eron, Joseph, Javan, Arzhang Cyrus, Hughes, Michael, Moser, Carlee, Giganti, Mark, Ritz, Justin, Hosey, Lara, Roa, Jhoanna, Patel, Nilam, Colsh, Kelly, Rwakazina, Irene, Beck, Justine, Sieg, Scott, Li, Jonathan, Fletcher, Courtney, Fischer, William, Evering, Teresa, Ignacio, Rachel Bender, Cardoso, Sandra, Corado, Katya, Jagannathan, Prasanna, Jilg, Nikolaus, Perelson, Alan, Pillay, Sandy, Riviere, Cynthia, Singh, Upinder, Taiwo, Babafemi, Gottesman, Joan, Newell, Matthew, Pedersen, Susan, Dragavon, Joan, Jennings, Cheryl, Greenfelder, Brian, Murtaugh, William, Kosmyna, Jan, Gapara, Morgan, Shahkolahi, Akbar

“…Abstract Background We evaluated the fully human polyclonal antibody product SAB-185 in a phase 3 trial for COVID-19. Methods Nonhospitalized high-risk adults…”
Get full text